The long-term development path of the global Thrombopoietin Receptor Agonist Market is deeply intertwined with macro-level economic shifts, inflation cycles, and changing national healthcare budgets. As governments face rising fiscal strain, public healthcare administrators are executing strict cost-containment measures, demanding clear proof of a drug's value before approving large-scale...